UCSF researchers identify new metabolic biomarkers that could indicate higher risk for Sudden Infant Death Syndrome (SIDS) in infants.

Scientists discover how to drug GTPases, a group of 150 critical enzymes that act like "switches" in cells, which cause a wide variety of diseases such as cancer and Parkinson’s disease when mutated.

For the 2024-2025 academic year, UCSF School of Dentistry extends its Community Based Clinical Education to third-year students, previously limited to fourth-year learners.

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

For more than 30 years, UCSF has run a 10-week summer internship program for 40-54 health/life sciences undergraduates. Students are assigned to a lab at UCSF and conduct research, which they present at the end of the program.

The UCSF Prostate Cancer Program will receive about $7 million from the National Cancer Institute to develop new approaches to the prevention, early detection, diagnosis and treatment of prostate cancer.

A new video-based symptom assessment system for Parkinson’s Disease that is enabled by machine learning represents a potential solution to the challenge of assessing Parkinson’s Disease progression in a quantifiable way.